Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Vyth

Showing results (31-40 of 59) with videos related to

Pageof 6
Sort By:
Leukemia|August 1, 1989
Functional and molecular characterization of B cell line derived interleukin-1 alphaF A Vyth-Dreese, A Hekman, J Wijffels, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 24, 2004
Analysis of autoreactive CD4 T cells in experimental autoimmune encephalomyelitis after primary and secondary challenge using MHC class II tetramersFelix Bischof, Matthias Hofmann, Ton N M Schumacher, et al.
Immunobiology|January 1, 1982
The replacement of monocytes and interleukin-1 by phorbol ester in lectin-induced proliferation of human thymocytes and T cellsJ E de Vries, F A Vyth-Dreese, R van der Hulst, et al.
Journal of Immunological Methods|February 21, 2006
In situ visualization of antigen-specific T cells in cryopreserved human tissuesFlorry A Vyth-Dreese, Yeung-Hyen Kim, Trees A M Dellemijn, et al.
Nature Medicine|September 6, 2000
In situ detection of virus- and tumor-specific T-cell immunityJ B Haanen, M G van Oijen, F Tirion, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1993
Enhancement of the antibody-dependent cellular cytotoxicity of human peripheral blood lymphocytes with interleukin-2 and interferon alphaW M Vuist, M J Visseren, M Otsen, et al.
Nature Immunology|February 16, 2005
STAT5 regulates the self-renewal capacity and differentiation of human memory B cells and controls Bcl-6 expressionFerenc A Scheeren, Marianne Naspetti, Sean Diehl, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1995
Treatment of low-grade non-Hodgkin's lymphoma with continuous infusion of low-dose recombinant interleukin-2 in combination with the B-cell-specific monoclonal antibody CLB-CD19L T Vlasveld, A Hekman, F A Vyth-Dreese, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 10, 2002
Differential kinetics of antigen-specific CD4+ and CD8+ T cell responses in the regression of retrovirus-induced sarcomasKoen Schepers, Mireille Toebes, Gitte Sotthewes, et al.
British Journal of Cancer|May 1, 1992
A phase I study of prolonged continuous infusion of low dose recombinant interleukin-2 in melanoma and renal cell cancer. Part I: Clinical aspectsL T Vlasveld, E M Rankin, A Hekman, et al.
Pageof 6

Showing results (31-40 of 59) with videos related to

Sort By:
Pageof 6
Leukemia|August 1, 1989
Functional and molecular characterization of B cell line derived interleukin-1 alphaF A Vyth-Dreese, A Hekman, J Wijffels, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 24, 2004
Analysis of autoreactive CD4 T cells in experimental autoimmune encephalomyelitis after primary and secondary challenge using MHC class II tetramersFelix Bischof, Matthias Hofmann, Ton N M Schumacher, et al.
Immunobiology|January 1, 1982
The replacement of monocytes and interleukin-1 by phorbol ester in lectin-induced proliferation of human thymocytes and T cellsJ E de Vries, F A Vyth-Dreese, R van der Hulst, et al.
Journal of Immunological Methods|February 21, 2006
In situ visualization of antigen-specific T cells in cryopreserved human tissuesFlorry A Vyth-Dreese, Yeung-Hyen Kim, Trees A M Dellemijn, et al.
Nature Medicine|September 6, 2000
In situ detection of virus- and tumor-specific T-cell immunityJ B Haanen, M G van Oijen, F Tirion, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1993
Enhancement of the antibody-dependent cellular cytotoxicity of human peripheral blood lymphocytes with interleukin-2 and interferon alphaW M Vuist, M J Visseren, M Otsen, et al.
Nature Immunology|February 16, 2005
STAT5 regulates the self-renewal capacity and differentiation of human memory B cells and controls Bcl-6 expressionFerenc A Scheeren, Marianne Naspetti, Sean Diehl, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1995
Treatment of low-grade non-Hodgkin's lymphoma with continuous infusion of low-dose recombinant interleukin-2 in combination with the B-cell-specific monoclonal antibody CLB-CD19L T Vlasveld, A Hekman, F A Vyth-Dreese, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 10, 2002
Differential kinetics of antigen-specific CD4+ and CD8+ T cell responses in the regression of retrovirus-induced sarcomasKoen Schepers, Mireille Toebes, Gitte Sotthewes, et al.
British Journal of Cancer|May 1, 1992
A phase I study of prolonged continuous infusion of low dose recombinant interleukin-2 in melanoma and renal cell cancer. Part I: Clinical aspectsL T Vlasveld, E M Rankin, A Hekman, et al.
Pageof 6